Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2011 (2011), Article ID 828369, 7 pages
http://dx.doi.org/10.4061/2011/828369
Review Article

Endothelial Progenitor Cells in Acute Ischemic Kidney Injury: Strategies for Increasing the Cells' Renoprotective Competence

Department of Nephrology and Rheumatology, University Medical Center, Robert-Koch-Straße 40, 37075 Göttingen, Germany

Received 13 December 2010; Accepted 1 March 2011

Academic Editor: Michael S. Goligorsky

Copyright © 2011 D. Patschan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kribben, S. Herget-Rosenthal, F. Pietruck, and TH. Philipp, “Acute renal failure—an update,” Deutsche Medizinische Wochenschrift, vol. 128, no. 22, pp. 1231–1236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Basile, “The long-term prognosis of acute kidney injury: acute renal failure as a cause of chronic kidney disease,” Journal of Nephrology, vol. 21, no. 5, pp. 657–662, 2008. View at Google Scholar · View at Scopus
  3. N. Srisawat, E. E. A. Hoste, and J. A. Kellum, “Modern classification of acute kidney injury,” Blood Purification, vol. 29, no. 3, pp. 300–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. V. Brodsky, T. Yamamoto, T. Tada et al., “Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells,” American Journal of Physiology, vol. 282, no. 6, pp. F1140–F1149, 2002. View at Google Scholar · View at Scopus
  5. T. Yamamoto, T. Tada, S. V. Brodsky et al., “Intravital videomicroscopy of peritubular capillaries in renal ischemia,” American Journal of Physiology, vol. 282, no. 6, pp. F1150–F1155, 2002. View at Google Scholar · View at Scopus
  6. J. Flores, D. R. DiBona, C. H. Beck, and A. Leaf, “The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute,” Journal of Clinical Investigation, vol. 51, no. 1, pp. 118–126, 1972. View at Google Scholar · View at Scopus
  7. A. Leaf, “Cell swelling: a factor in ischemic tissue injury,” Circulation, vol. 48, no. 3, pp. 455–458, 1973. View at Google Scholar · View at Scopus
  8. D. P. Basile, “The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function,” Kidney International, vol. 72, no. 2, pp. 151–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. P. Basile, D. Donohoe, K. Roethe, and J. L. Osborn, “Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function,” American Journal of Physiology, vol. 281, no. 5, pp. F887–F899, 2001. View at Google Scholar · View at Scopus
  10. A. Aicher, A. M. Zeiher, and S. Dimmeler, “Mobilizing endothelial progenitor cells,” Hypertension, vol. 45, no. 3, pp. 321–325, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Urbich and S. Dimmeler, “Endothelial progenitor cells: characterization and role in vascular biology,” Circulation Research, vol. 95, no. 4, pp. 343–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Urbich and S. Dimmeler, “Endothelial progenitor cells: functional characterization,” Trends in Cardiovascular Medicine, vol. 14, no. 8, pp. 318–322, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Y. Khakoo and T. Finkel, “Endothelial progenitor cells,” Annual Review of Medicine, vol. 56, pp. 79–101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. S. Bailey, S. Jiang, M. Afentoulis et al., “Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells,” Blood, vol. 103, no. 1, pp. 13–19, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. B. Grant, W. S. May, S. Caballero et al., “Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization,” Nature Medicine, vol. 8, no. 6, pp. 607–612, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Adams, K. Lenk, A. Linke et al., “Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 684–690, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Google Scholar · View at Scopus
  19. B. Assmus, J. Honold, V. Schächinger et al., “Transcoronary transplantation of progenitor cells after myocardial infarction,” New England Journal of Medicine, vol. 355, no. 12, pp. 1222–1232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Heeschen, A. Aicher, R. Lehmann et al., “Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization,” Blood, vol. 102, no. 4, pp. 1340–1346, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Kawamoto and T. Asahara, “Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies,” Catheterization and Cardiovascular Interventions, vol. 70, no. 4, pp. 477–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Kawamoto, T. Asahara, and D. W. Losordo, “Transplantation of endothelial progenitor cells for therapeutic neovascularization,” Cardiovascular Radiation Medicine, vol. 3, no. 3-4, pp. 221–225, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Kawamoto, H. C. Gwon, H. Iwaguro et al., “Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia,” Circulation, vol. 103, no. 5, pp. 634–637, 2001. View at Google Scholar · View at Scopus
  24. D. Patschan, K. Krupincza, S. Patschan, Z. Zhang, C. Hamby, and M. S. Goligorsky, “Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: modulation by ischemic preconditioning,” American Journal of Physiology, vol. 291, no. 1, pp. F176–F185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Patschan, S. Patschan, J. T. Wessels et al., “Epac-1 activator 8-O-cAMP augments renoprotective effects of allogeneic murine EPCs in acute ischemic kidney injury,” American Journal of Physiology, vol. 298, no. 1, pp. F78–F85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Patschan, M. Plotkin, and M. S. Goligorsky, “Therapeutic use of stem and endothelial progenitor cells in acute renal injury: Ça ira,” Current Opinion in Pharmacology, vol. 6, no. 2, pp. 176–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. C. Yoder and D. A. Ingram, “The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process?” Biochimica et Biophysica Acta, vol. 1796, no. 1, pp. 50–54, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. C. Yoder, L. E. Mead, D. Prater et al., “Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals,” Blood, vol. 109, no. 5, pp. 1801–1809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Takahashi, C. Kalka, H. Masuda et al., “Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization,” Nature Medicine, vol. 5, no. 4, pp. 434–438, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Case, L. E. Mead, W. K. Bessler et al., “Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors,” Experimental Hematology, vol. 35, no. 7, pp. 1109–1118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. A. Ingram, N. M. Caplice, and M. C. Yoder, “Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells,” Blood, vol. 106, no. 5, pp. 1525–1531, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Patschan, S. Patschan, E. Henze, J. T. Wessels, M. Koziolek, and G. A. Müller, “LDL lipid apheresis rapidly increases peripheral endothelial progenitor cell competence,” Journal of Clinical Apheresis, vol. 24, no. 5, pp. 180–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. S. Goligorsky, K. Yasuda, and B. Ratliff, “Dysfunctional endothelial progenitor cells in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 21, no. 6, pp. 911–919, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Lapergue, A. Mohammad, and A. Shuaib, “Endothelial progenitor cells and cerebrovascular diseases,” Progress in Neurobiology, vol. 83, no. 6, pp. 349–362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. T. J. Povsic and P. J. Goldschmidt-Clermont, “Endothelial progenitor cells: markers of vascular reparative capacity,” Therapeutic Advances in Cardiovascular Disease, vol. 2, no. 3, pp. 199–213, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Assmus, U. Fischer-Rasokat, J. Honold et al., “Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD registry,” Circulation Research, vol. 100, no. 8, pp. 1234–1241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Fan, F. Shen, T. Frenzel et al., “Endothelial progenitor cell transplantation improves long-term stroke outcome in mice,” Annals of Neurology, vol. 67, no. 4, pp. 488–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. P. D. Lambiase, R. J. Edwards, P. Anthopoulos et al., “Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support,” Circulation, vol. 109, no. 24, pp. 2986–2992, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Murasawa and T. Asahara, “Cardiogenic potential of endothelial progenitor cells,” Therapeutic Advances in Cardiovascular Disease, vol. 2, no. 5, pp. 341–348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. R. G. Shaffer, S. Greene, A. Arshi et al., “Effect of acute exercise on endothelial progenitor cells in patients with peripheral arterial disease,” Vascular Medicine, vol. 11, no. 4, pp. 219–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. G. Zhang, L. Zhang, Q. Jiang, and M. Chopp, “Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse,” Circulation Research, vol. 90, no. 3, pp. 284–288, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Minamino, H. Miyauchi, T. Yoshida, Y. Ishida, H. Yoshida, and I. Komuro, “Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction,” Circulation, vol. 105, no. 13, pp. 1541–1544, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. K. De Groot, F. H. Bahlmann, J. Sowa et al., “Uremia causes endothelial progenitor cell deficiency,” Kidney International, vol. 66, no. 2, pp. 641–646, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Ergün, D. Tilki, H. P. Hohn, U. Gehling, and N. Kilic, “Potential implications of vascular wall resident endothelial progenitor cells,” Thrombosis and Haemostasis, vol. 98, no. 5, pp. 930–939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Taguchi, T. Soma, H. Tanaka et al., “Administration of CD34 cells after stroke enhances neurogenesis via angiogenesis in a mouse model,” Journal of Clinical Investigation, vol. 114, no. 3, pp. 330–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Shintani, T. Murohara, H. Ikeda et al., “Mobilization of endothelial progenitor cells in patients with acute myocardial infarction,” Circulation, vol. 103, no. 23, pp. 2776–2779, 2001. View at Google Scholar · View at Scopus
  47. J. Rehman, J. Li, C. M. Orschell, and K. L. March, “Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors,” Circulation, vol. 107, no. 8, pp. 1164–1169, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Pula, U. Mayr, C. Evans et al., “Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures,” Circulation Research, vol. 104, no. 1, pp. 32–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Lin, D. J. Weisdorf, A. Solovey, and R. P. Hebbel, “Origins of circulating endothelial cells and endothelial outgrowth from blood,” Journal of Clinical Investigation, vol. 105, no. 1, pp. 71–77, 2000. View at Google Scholar · View at Scopus
  50. C. Moubarik, B. Guillet, B. Youssef et al., “Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke,” Stem Cell Reviews and Reports, vol. 7, no. 1, pp. 208–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S. H. Wang, S. J. Lin, Y. H. Chen et al., “Late outgrowth endothelial cells derived from wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 6, pp. 816–822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Murohara, “Cord blood-derived early outgrowth endothelial progenitor cells,” Microvascular Research, vol. 79, no. 3, pp. 174–177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. Q. Xu, “Progenitor cells in vascular repair,” Current Opinion in Lipidology, vol. 18, no. 5, pp. 534–539, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. D. Schuster, A. A. Kocher, T. Seki et al., “Myocardial neovascularization by bone marrow angioblasts results in cardiomyocyte regeneration,” American Journal of Physiology, vol. 287, no. 2, pp. H525–H532, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Patschan, S. Patschan, G. G. Gobe, S. Chintala, and M. S. Goligorsky, “Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells,” Journal of the American Society of Nephrology, vol. 18, no. 5, pp. 1516–1524, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. C. Kuo, D. Patschan, S. Patschan et al., “Ischemia-induced exocytosis of Weibel-Palade bodies mobilizes stem cells,” Journal of the American Society of Nephrology, vol. 19, no. 12, pp. 2321–2330, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Kong, L. G. Melo, A. A. Mangi et al., “Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells,” Circulation, vol. 109, no. 14, pp. 1769–1775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Murasawa, J. Llevadot, M. Silver, J. M. Isner, D. W. Losordo, and T. Asahara, “Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells,” Circulation, vol. 106, no. 9, pp. 1133–1139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Yamamizu, K. Kawasaki, S. Katayama, T. Watabe, and J. K. Yamashita, “Enhancement of vascular progenitor potential by protein kinase a through dual induction of Flk-1 and Neuropilin-1,” Blood, vol. 114, no. 17, pp. 3707–3716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Berndorff, R. Gessner, B. Kreft et al., “Liver-intestine cadherin: molecular cloning and characterization of a novel Ca-dependent cell adhesion molecule expressed in liver and intestine,” Journal of Cell Biology, vol. 125, no. 6, pp. 1353–1369, 1994. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Kreft, D. Berndorff, A. Böttinger et al., “LI-cadherin-mediated cell-cell adhesion does not require cytoplasmic interactions,” Journal of Cell Biology, vol. 136, no. 5, pp. 1109–1121, 1997. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Arcangeli and A. Becchetti, “Integrin structure and functional relation with ion channels,” Advances in Experimental Medicine and Biology, vol. 674, pp. 1–7, 2010. View at Google Scholar
  63. M. J. Humphries, “Integrin structure,” Biochemical Society Transactions, vol. 28, no. 4, pp. 311–340, 2000. View at Google Scholar · View at Scopus
  64. A. Byron, J. D. Humphries, J. A. Askari, S. E. Craig, A. P. Mould, and M. J. Humphries, “Anti-integrin monoclonal antibodies,” Journal of Cell Science, vol. 122, no. 22, pp. 4009–4011, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. H. S. Baldwin, H. M. Shen, H. C. Yan et al., “Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development,” Development, vol. 120, no. 9, pp. 2539–2553, 1994. View at Google Scholar · View at Scopus
  66. G. Carmona, E. Chavakis, U. Koehl, A. M. Zeiher, and S. Dimmeler, “Activation of Epac stimulates integrin-dependent homing of progenitor cells,” Blood, vol. 111, no. 5, pp. 2640–2646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Gloerich and J. L. Bos, “Epac: defining a new mechanism for cAMP action,” Annual Review of Pharmacology and Toxicology, vol. 50, pp. 355–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. S. Elitok, S. V. Brodsky, D. Patschan et al., “Cyclic arginine-glycine-aspartic acid peptide inhibits macrophage infiltration of the kidney and carotid artery lesions in apo-E-deficient mice,” American Journal of Physiology, vol. 290, no. 1, pp. F159–F166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Thurston, “Role of angiopoietins and tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis,” Cell and Tissue Research, vol. 314, no. 1, pp. 61–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. T. M. Hansen, H. Singh, T. A. Tahir, and N. P. J. Brindle, “Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface,” Cellular Signalling, vol. 22, no. 3, pp. 527–532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. K. Noda, J. Zhang, S. Fukuhara, S. Kunimoto, M. Yoshimura, and N. Mochizuki, “Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through α- and β-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells,” Molecular Biology of the Cell, vol. 21, no. 4, pp. 584–596, 2010. View at Publisher · View at Google Scholar
  72. R. J. Reiter, D. X. Tan, and L. Fuentes-Broto, “Melatonin: a multitasking molecule,” Progress in Brain Research, vol. 181, pp. 127–151, 2010. View at Google Scholar
  73. S. Perreau-Lenz, P. Pévet, R. M. Buijs, and A. Kalsbeek, “The biological clock: the bodyguard of temporal homeostasis,” Chronobiology International, vol. 21, no. 1, pp. 1–25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. G. S. Richardson, “The human circadian system in normal and disordered sleep,” Journal of Clinical Psychiatry, vol. 66, no. 9, pp. 3–9, 2005. View at Google Scholar · View at Scopus
  75. E. R. V. Rios, E. T. Venncio, N. F. M. Rocha et al., “Melatonin: pharmacological aspects and clinical trends,” International Journal of Neuroscience, vol. 120, no. 9, pp. 583–590, 2010. View at Publisher · View at Google Scholar
  76. C. Mias, E. Trouche, M. H. Seguelas et al., “Ex vivo pretreatment with melatonin improves survival, proangiogenic/ mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney,” Stem Cells, vol. 26, no. 7, pp. 1749–1757, 2008. View at Publisher · View at Google Scholar · View at Scopus